Maxeon Sues Canadian Solar for Patent Infringement-February 2024-www.financetom.com

Maxeon Sues Canadian Solar for Patent Infringement

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Maxeon Sues Canadian Solar for Patent Infringement

Mar 25, 2024 2:35 PM

05:24 PM EDT, 03/25/2024 (MT Newswires) -- Maxeon Solar Technologies ( MAXN ) said Monday it filed a patent infringement lawsuit against Canadian Solar ( CSIQ ) in the US District Court for the Eastern District of Texas.

The lawsuit claims Canadian Solar ( CSIQ ) infringed Maxeon's patents relating to Tunnel Oxide Passivated Contact solar cell technology, according to the company.

Canadian Solar ( CSIQ ) did not immediately respond to MT Newswires' request for comment.

Price: 3.11, Change: -0.01, Percent Change: -0.32

Previous page： RingCentral Q2 Adjusted Earnings, Revenue Rise; Raises 2025 Earnings Outlook Next page： Canada's PHX Energy Q2 revenue beats estimates

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

RingCentral Q2 Adjusted Earnings, Revenue Rise; Raises 2025 Earnings Outlook

Aug 5, 2025

06:05 PM EDT, 08/05/2025 (MT Newswires) -- RingCentral ( RNG ) reported fiscal Q2 non-GAAP net income late Tuesday of $1.06 per diluted share, up from $0.91 a year earlier. Analysts polled by FactSet expected $1.02. Revenue for the quarter ended June 30 was $620.4 million, up from $592.9 million a year earlier. Analysts expected $617.8 million. For fiscal Q3,...

Canada's PHX Energy Q2 revenue beats estimates

Aug 5, 2025

Overview * PHX Energy Q2 2025 revenue rises 9%, beating analyst expectations, per LSEG data * Adjusted EBITDA for Q2 2025 declines 9% due to higher equipment costs * Company repurchased 100,000 shares, plans to renew NCIB strategy Outlook * PHX Energy expects strong activity and revenue in H2 2025 * Company anticipates continued growth in Canadian RSS fleet *...

US FDA approves Teva's Ajovy for migraine prevention in children

Aug 5, 2025

Aug 5 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva Pharma, to help prevent migraines in children aged six and older who weigh 45 kilograms or more. This is the first time a drug has been approved for preventing migraines in children. The injection is given once a month....

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...